No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BWAYBrainsWay Ltd. | 452.42M | 23.10 | 128.33 | 29.04% | 12.73% | 8.92% | 1.44% | 0.09 |
| INSPInspire Medical Systems, Inc. | 2.8B | 96.47 | 55.13 | 28.49% | 5.05% | 6.69% | 3.25% | 0.05 |
| TIVCTivic Health Systems, Inc. | 3.11M | 1.23 | -0.06 | -33.67% | -15.57% | -134.25% | ||
| COCHEnvoy Medical, Inc. | 19.42M | 0.67 | -0.45 | -28.8% | -104.75% | |||
| HSDTSolana Company | 128.03M | 3.10 | -0.72 | -19.25% | -393.59% | -6.89% | 0.01 | |
| NXLNexalin Technology, Inc. | 12.87M | 0.69 | -0.83 | 52.35% | -55.3% | -182.01% | ||
| CVRXCVRx, Inc. | 143.37M | 5.47 | -2.06 | 30.53% | -92.95% | -108.26% | 0.71 | |
| VANIVivani Medical, Inc. | 91.92M | 1.26 | -2.93 | -19.88% | 1.10 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 207.38K | 242.91K | 144.06K | 1.32M | 110.75K | 168.72K |
| Revenue Growth % | - | 0.17% | -0.41% | 8.17% | -0.92% | 0.52% |
| Cost of Goods Sold | 218.21K | 29.04K | 21.44K | 363.21K | 25.69K | 36.59K |
| COGS % of Revenue | 1.05% | 0.12% | 0.15% | 0.27% | 0.23% | 0.22% |
| Gross Profit | -10.83K | 213.88K | 122.62K | 958.14K | 85.06K | 132.13K |
| Gross Margin % | -0.05% | 0.88% | 0.85% | 0.73% | 0.77% | 0.78% |
| Gross Profit Growth % | - | 20.75% | -0.43% | 6.81% | -0.91% | 0.55% |
| Operating Expenses | 1.46M | 3.47M | 6.14M | 2.79M | 5.78M | 7.89M |
| OpEx % of Revenue | 7.02% | 14.29% | 42.63% | 2.11% | 52.2% | 46.74% |
| Selling, General & Admin | 1.46M | 3.47M | 6.14M | 2.79M | 3.86M | 6.7M |
| SG&A % of Revenue | 7.02% | 14.29% | 42.63% | 2.11% | 34.85% | 39.69% |
| Research & Development | 0 | 0 | 139K | 511K | 1.92M | 1.19M |
| R&D % of Revenue | - | - | 0.96% | 0.39% | 17.35% | 7.06% |
| Other Operating Expenses | 0 | 0 | -139K | -511K | -189 | -116 |
| Operating Income | -1.47M | -3.26M | -6.02M | -1.83M | -5.7M | -7.75M |
| Operating Margin % | -7.07% | -13.41% | -41.78% | -1.39% | -51.43% | -45.96% |
| Operating Income Growth % | - | -1.22% | -0.85% | 0.7% | -2.11% | -0.36% |
| EBITDA | -1.47M | -3.26M | -6.02M | -1.83M | -5.69M | -7.74M |
| EBITDA Margin % | -7.07% | -13.41% | -41.77% | -1.38% | -51.4% | -45.87% |
| EBITDA Growth % | - | -1.22% | -0.85% | 0.7% | -2.11% | -0.36% |
| D&A (Non-Cash Add-back) | 535 | 429 | 537 | 5.72K | 4.25K | 15.11K |
| EBIT | -1.47M | -3.32M | -6M | -1.83M | -5.7M | -7.75M |
| Net Interest Income | 0 | -78.68K | -82.32K | -59.38K | -38.84K | 3.19K |
| Interest Income | 80.99K | 0 | 0 | 0 | 0 | 3.19K |
| Interest Expense | 80.99K | 78.68K | 82.32K | 59.38K | 38.84K | 0 |
| Other Income/Expense | -3.56M | -145.08K | -59.4K | 135.22K | 1.05M | 147.46K |
| Pretax Income | -5.02M | -3.4M | -6.08M | -1.7M | -4.65M | -7.61M |
| Pretax Margin % | -24.21% | -14.01% | -42.19% | -1.28% | -41.98% | -45.09% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -5.02M | -3.4M | -6.08M | -1.7M | -4.65M | -7.61M |
| Net Margin % | -24.21% | -14.01% | -42.19% | -1.28% | -41.98% | -45.09% |
| Net Income Growth % | - | 0.32% | -0.79% | 0.72% | -1.74% | -0.64% |
| Net Income (Continuing) | -5.02M | -3.4M | -6.08M | -1.7M | -4.65M | -7.61M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.69 | -0.47 | -0.83 | -0.23 | -0.63 | -0.83 |
| EPS Growth % | - | 0.32% | -0.77% | 0.72% | -1.74% | -0.32% |
| EPS (Basic) | -0.69 | -0.47 | -0.83 | -0.23 | -0.63 | -0.83 |
| Diluted Shares Outstanding | 7.28M | 7.28M | 7.28M | 7.29M | 7.36M | 9.22M |
| Basic Shares Outstanding | 7.28M | 7.28M | 7.28M | 7.29M | 7.36M | 9.22M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 111.15K | 116.89K | 752.66K | 7.43M | 3.43M | 3.96M |
| Cash & Short-Term Investments | 63.43K | 78.44K | 661.78K | 6.99M | 2.95M | 3.48M |
| Cash Only | 63.43K | 78.44K | 661.78K | 162.74K | 580.23K | 574.49K |
| Short-Term Investments | 0 | 0 | 0 | 6.83M | 2.37M | 2.91M |
| Accounts Receivable | 5.69K | 6.6K | 16.3K | 4.88K | 9.37K | 13.04K |
| Days Sales Outstanding | 10.01 | 9.92 | 41.3 | 1.35 | 30.88 | 28.22 |
| Inventory | 21.6K | 22.66K | 31.41K | 154.37K | 156.42K | 174.58K |
| Days Inventory Outstanding | 36.13 | 284.77 | 534.68 | 155.13 | 2.22K | 1.74K |
| Other Current Assets | 0 | 0 | 0 | 272.28K | 0 | 293.6K |
| Total Non-Current Assets | 1.36K | 1.58K | 1.04K | 6.67K | 202.02K | 261.59K |
| Property, Plant & Equipment | 1.36K | 1.58K | 1.04K | 6.67K | 496 | 0 |
| Fixed Asset Turnover | 152.82x | 154.13x | 138.66x | 197.99x | 223.28x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 105.53K | 260.73K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 96K | 864 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 112.51K | 118.46K | 753.7K | 7.43M | 3.63M | 4.22M |
| Asset Turnover | 1.84x | 2.05x | 0.19x | 0.18x | 0.03x | 0.04x |
| Asset Growth % | - | 0.05% | 5.36% | 8.86% | -0.51% | 0.16% |
| Total Current Liabilities | 1.04M | 1.57M | 2.36M | 1.95M | 425.28K | 546.69K |
| Accounts Payable | 324.47K | 461.16K | 843.79K | 658.37K | 159.53K | 155.95K |
| Days Payables Outstanding | 542.74 | 5.8K | 14.36K | 661.61 | 2.27K | 1.56K |
| Short-Term Debt | 551.67K | 546.8K | 737.2K | 700K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 130K | 0 | 0 | 0 |
| Other Current Liabilities | 25.76K | 336K | 0 | 336K | 89.33K | 390.75K |
| Current Ratio | 0.11x | 0.07x | 0.32x | 3.81x | 8.07x | 7.25x |
| Quick Ratio | 0.09x | 0.06x | 0.31x | 3.73x | 7.70x | 6.93x |
| Cash Conversion Cycle | -496.6 | -5.5K | -13.79K | -505.13 | -13.37 | 214.03 |
| Total Non-Current Liabilities | 250K | 142.24K | 72K | 4.46K | 0 | 0 |
| Long-Term Debt | 154.82K | 52.3K | 22.92K | 0 | 0 | 0 |
| Capital Lease Obligations | 95.18K | 89.93K | 49.09K | 4.46K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.29M | 1.71M | 2.44M | 1.95M | 425.28K | 546.69K |
| Total Debt | 826.77K | 726.01K | 850.05K | 755.26K | 4.46K | 0 |
| Net Debt | 763.34K | 647.58K | 188.27K | 592.52K | -575.77K | -574.49K |
| Debt / Equity | - | - | - | 0.14x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - |
| Interest Coverage | -18.10x | -41.41x | -73.11x | -30.87x | -146.68x | - |
| Total Equity | -1.18M | -1.59M | -1.68M | 5.48M | 3.21M | 3.68M |
| Equity Growth % | - | -0.35% | -0.06% | 4.26% | -0.41% | 0.15% |
| Book Value per Share | -0.16 | -0.22 | -0.23 | 0.75 | 0.44 | 0.40 |
| Total Shareholders' Equity | -1.18M | -1.59M | -1.68M | 5.48M | 3.21M | 3.68M |
| Common Stock | 3.14K | 3.69K | 4.88K | 7.29K | 7.44K | 13.3K |
| Retained Earnings | -61.21M | -64.61M | -70.69M | -72.39M | -77.04M | -84.65M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 36.31K | -405 | -513 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -678.34K | -863.47K | -1.08M | -2.22M | -3.84M | -3.94M |
| Operating CF Margin % | -3.27% | -3.55% | -7.47% | -1.68% | -34.63% | -23.38% |
| Operating CF Growth % | - | -0.27% | -0.25% | -1.06% | -0.73% | -0.03% |
| Net Income | -5.02M | -3.4M | -6.08M | -1.7M | -4.65M | -7.61M |
| Depreciation & Amortization | 535 | 429 | 537 | 535 | 4.25K | 15.11K |
| Stock-Based Compensation | 0 | 1.96M | 4.48M | 270.67K | 2.41M | 3.56M |
| Deferred Taxes | 0 | 66.4K | -4.11M | 0 | 0 | 0 |
| Other Non-Cash Items | 4.05M | 8.82K | 4.11M | -155.02K | -835.44K | -34.48K |
| Working Capital Changes | 288.73K | 504.84K | 522.64K | -634.07K | -768.86K | 121.65K |
| Change in Receivables | 7.17K | -909 | -9.7K | 253 | -4.49K | -3.67K |
| Change in Inventory | 5.9K | -1.06K | -8.75K | -142.85K | -7.81K | -18.16K |
| Change in Payables | 277.94K | 525.99K | 382.63K | -185.43K | -498.83K | -3.58K |
| Cash from Investing | 0 | -648 | 0 | -6.79M | 4.45M | -577.54K |
| Capital Expenditures | 0 | -648 | 0 | 0 | -109.28K | -170.31K |
| CapEx % of Revenue | 0% | 0% | - | - | 0.99% | 1.01% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 96K | 0 |
| Cash from Financing | 726.05K | 879.13K | 1.66M | 8.51M | -200K | 4.52M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 35.97K | 3.47K | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -678.34K | -864.12K | -1.08M | -2.22M | -3.94M | -3.94M |
| FCF Margin % | -3.27% | -3.56% | -7.47% | -1.68% | -35.62% | -23.38% |
| FCF Growth % | - | -0.27% | -0.25% | -1.06% | -0.78% | 0% |
| FCF per Share | -0.09 | -0.12 | -0.15 | -0.30 | -0.54 | -0.43 |
| FCF Conversion (FCF/Net Income) | 0.14x | 0.25x | 0.18x | 1.31x | 0.83x | 0.52x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -89.44% | -107.05% | -221.05% |
| Return on Invested Capital (ROIC) | - | - | - | -60.07% | -98.19% | -202.92% |
| Gross Margin | -5.22% | 88.05% | 85.12% | 72.51% | 76.81% | 78.31% |
| Net Margin | -2421.22% | -1401.11% | -4218.93% | -128.49% | -4197.56% | -4508.73% |
| Debt / Equity | - | - | - | 0.14x | 0.00x | - |
| Interest Coverage | -18.10x | -41.41x | -73.11x | -30.87x | -146.68x | - |
| FCF Conversion | 0.14x | 0.25x | 0.18x | 1.31x | 0.83x | 0.52x |
| Revenue Growth | - | 17.13% | -40.69% | 817.2% | -91.62% | 52.35% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Licensing Fee | 79.19K | 82.08K | 69.5K |
| Licensing Fee Growth | - | 3.65% | -15.33% |
| Device Sales | 1.16M | - | 55.5K |
| Device Sales Growth | - | - | - |
| Equipment | 26.78K | 27.3K | 37.83K |
| Equipment Growth | - | 1.95% | 38.56% |
| Other | 26.41K | 1.37K | 5.89K |
| Other Growth | - | -94.82% | 330.53% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| CHINA | 1.21M | 3.61K | 85.25K |
| CHINA Growth | - | -99.70% | 2258.83% |
| UNITED STATES | 113.54K | 107.13K | 83.47K |
| UNITED STATES Growth | - | -5.64% | -22.09% |
Nexalin Technology, Inc. (NXL) reported $0.2M in revenue for fiscal year 2024. This represents a 24% decrease from $0.2M in 2019.
Nexalin Technology, Inc. (NXL) grew revenue by 52.3% over the past year. This is strong growth.
Nexalin Technology, Inc. (NXL) reported a net loss of $8.7M for fiscal year 2024.
Nexalin Technology, Inc. (NXL) has a return on equity (ROE) of -221.1%. Negative ROE indicates the company is unprofitable.
Nexalin Technology, Inc. (NXL) had negative free cash flow of $5.0M in fiscal year 2024, likely due to heavy capital investments.